537 related articles for article (PubMed ID: 30783071)
1. Improving Pleasure and Motivation in Schizophrenia: A Randomized Controlled Clinical Trial.
Favrod J; Nguyen A; Chaix J; Pellet J; Frobert L; Fankhauser C; Ismailaj A; Brana A; Tamic G; Suter C; Rexhaj S; Golay P; Bonsack C
Psychother Psychosom; 2019; 88(2):84-95. PubMed ID: 30783071
[TBL] [Abstract][Full Text] [Related]
2. Positive Emotions Program for Schizophrenia (PEPS): a pilot intervention to reduce anhedonia and apathy.
Favrod J; Nguyen A; Fankhauser C; Ismailaj A; Hasler JD; Ringuet A; Rexhaj S; Bonsack C
BMC Psychiatry; 2015 Sep; 15():231. PubMed ID: 26419356
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
[TBL] [Abstract][Full Text] [Related]
4. Impact of Positive Emotion Regulation Training on Negative Symptoms and Social Functioning in Schizophrenia: A Field Test.
Favrod J; Nguyen A; Tronche AM; Blanc O; Dubreucq J; Chereau-Boudet I; Capdevielle D; Llorca PM
Front Psychiatry; 2019; 10():532. PubMed ID: 31404331
[No Abstract] [Full Text] [Related]
5. [The clinic of apathy in schizophrenia: a critical review of the issue].
Yazbek H; Raffard S; Del-Monte J; Pupier F; Larue A; Boulenger JP; Gély-Nargeot MC; Capdevielle D
Encephale; 2014 Jun; 40(3):231-9. PubMed ID: 23958346
[TBL] [Abstract][Full Text] [Related]
6. Development of the Positive Emotions Program for Schizophrenia: An Intervention to Improve Pleasure and Motivation in Schizophrenia.
Nguyen A; Frobert L; McCluskey I; Golay P; Bonsack C; Favrod J
Front Psychiatry; 2016; 7():13. PubMed ID: 26924992
[TBL] [Abstract][Full Text] [Related]
7. The brief negative symptom scale: validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathy.
Bischof M; Obermann C; Hartmann MN; Hager OM; Kirschner M; Kluge A; Strauss GP; Kaiser S
BMC Psychiatry; 2016 Nov; 16(1):415. PubMed ID: 27876020
[TBL] [Abstract][Full Text] [Related]
8. Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study.
Giordano GM; Koenig T; Mucci A; Vignapiano A; Amodio A; Di Lorenzo G; Siracusano A; Bellomo A; Altamura M; Monteleone P; Pompili M; Galderisi S; Maj M;
Neuroimage Clin; 2018; 20():627-636. PubMed ID: 30202724
[TBL] [Abstract][Full Text] [Related]
9. Anhedonia in schizophrenia: Deficits in both motivation and hedonic capacity.
Wang J; Huang J; Yang XH; Lui SS; Cheung EF; Chan RC
Schizophr Res; 2015 Oct; 168(1-2):465-74. PubMed ID: 26185892
[TBL] [Abstract][Full Text] [Related]
10. [Negative Symptoms Revisited--Toward the Recovery of Persons with Schizophrenia].
Ikebuchi E
Seishin Shinkeigaku Zasshi; 2015; 117(3):179-94. PubMed ID: 26524844
[TBL] [Abstract][Full Text] [Related]
11. Anticipatory pleasure skills training: a new intervention to reduce anhedonia in schizophrenia.
Favrod J; Giuliani F; Ernst F; Bonsack C
Perspect Psychiatr Care; 2010 Jul; 46(3):171-81. PubMed ID: 20591125
[TBL] [Abstract][Full Text] [Related]
12. Psychometric evaluation of the Temporal Experience of Pleasure Scale (TEPS) in a German sample.
Simon JJ; Zimmermann J; Cordeiro SA; Marée I; Gard DE; Friederich HC; Weisbrod M; Kaiser S
Psychiatry Res; 2018 Feb; 260():138-143. PubMed ID: 29195165
[TBL] [Abstract][Full Text] [Related]
13. Self-assessment of negative symptoms - Critical appraisal of the motivation and pleasure - Self-report's (MAP-SR) validity and reliability.
Richter J; Hesse K; Eberle MC; Eckstein KN; Zimmermann L; Schreiber L; Burmeister CP; Wildgruber D; Klingberg S
Compr Psychiatry; 2019 Jan; 88():22-28. PubMed ID: 30466014
[TBL] [Abstract][Full Text] [Related]
14. Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure.
Gard DE; Kring AM; Gard MG; Horan WP; Green MF
Schizophr Res; 2007 Jul; 93(1-3):253-60. PubMed ID: 17490858
[TBL] [Abstract][Full Text] [Related]
15. Executive dysfunctions differentially predict amotivation in first-episode schizophrenia-spectrum disorder: a prospective 1-year follow-up study.
Chang WC; Liu JTT; Hui CLM; Chan SKW; Lee EHM; Suen YN; Chen EYH
Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):887-896. PubMed ID: 29934845
[TBL] [Abstract][Full Text] [Related]
16. The Latent Structure of Negative Symptoms in Schizophrenia.
Strauss GP; Nuñez A; Ahmed AO; Barchard KA; Granholm E; Kirkpatrick B; Gold JM; Allen DN
JAMA Psychiatry; 2018 Dec; 75(12):1271-1279. PubMed ID: 30208377
[TBL] [Abstract][Full Text] [Related]
17. The interactive effects of negative symptoms and social role functioning on suicide ideation in individuals with schizophrenia.
Jahn DR; Bennett ME; Park SG; Gur RE; Horan WP; Kring AM; Blanchard JJ
Schizophr Res; 2016 Feb; 170(2-3):271-7. PubMed ID: 26746862
[TBL] [Abstract][Full Text] [Related]
18. The Relationship between Negative Symptoms and Both Emotion Management and Non-social Cognition in Schizophrenia Spectrum Disorders.
Yolland COB; Carruthers SP; Toh WL; Neill E; Sumner PJ; Thomas EHX; Tan EJ; Gurvich C; Phillipou A; Van Rheenen TE; Rossell SL
J Int Neuropsychol Soc; 2021 Oct; 27(9):916-928. PubMed ID: 33342446
[TBL] [Abstract][Full Text] [Related]
19. Individual negative symptoms and domains - Relevance for assessment, pathomechanisms and treatment.
Kaiser S; Lyne J; Agartz I; Clarke M; Mørch-Johnsen L; Faerden A
Schizophr Res; 2017 Aug; 186():39-45. PubMed ID: 27453425
[TBL] [Abstract][Full Text] [Related]
20. The cognitive, affective motivational and clinical longitudinal determinants of apathy in schizophrenia.
Raffard S; Bortolon C; Yazbek H; Lançon C; Benoit M; Norton J; Capdevielle D
Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):911-920. PubMed ID: 29948250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
